HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Canola oil compared with sesame and sesame-canola oil on glycaemic control and liver function in patients with type 2 diabetes: A three-way randomized triple-blind cross-over trial.

AbstractBACKGROUND:
This study aimed to compare the effects of sesame (SO), canola (CO), and sesame-canola (SCO: a blend) oils on glycaemic control markers and liver function enzymes in adults with type 2 diabetes.
METHODS:
In this randomized, triple-blind, three-way, cross-over clinical trial, participants replaced their usual oil with the intervention oils for 9 weeks. Serum fasting blood sugar, fasting serum insulin (FSI), insulin resistance (HOMA2-IR), beta-cell function (HOMA2-%B), insulin sensitivity (HOMA2-%S), quantitative insulin sensitivity check index (QUICKI), as well as serum liver function enzymes were measured at baseline and end of intervention periods.
RESULTS:
Ninety-two participants completed all treatment periods. After adjusting for confounders, all treatment oils resulted in significant improvements in FSI and HOMA2-%S (p < 0.05). SO and SCO led to favourable changes in HOMA2-IR and QUICKI (p < 0.05). Following CO and SCO, there was a significant decrease in HOMA2-%B (p < 0.05). The sex-stratified analysis revealed that FSI and HOMA2-IR were decreased after SO compared to CO in males (p = 0.024). Serum gamma-glutamyltransferase (GGT) was significantly lower following SO compared to CO in females (p = 0.02), however, the difference in change values was not significant (p = 0.058).
CONCLUSIONS:
SO consumption appears to improve glycaemic control markers in males and serum GGT in females compared with CO in patients with type 2 diabetes (registration code: IRCT2016091312571N6).
AuthorsHamidreza Raeisi-Dehkordi, Mojgan Amiri, Alireza Zimorovat, Fatemeh Moghtaderi, Sadegh Zarei, Scott C Forbes, Amin Salehi-Abargouei
JournalDiabetes/metabolism research and reviews (Diabetes Metab Res Rev) Vol. 37 Issue 5 Pg. e3399 (07 2021) ISSN: 1520-7560 [Electronic] England
PMID32860716 (Publication Type: Journal Article, Randomized Controlled Trial, Research Support, Non-U.S. Gov't)
Copyright© 2020 John Wiley & Sons Ltd.
Chemical References
  • Rapeseed Oil
  • Sesame Oil
Topics
  • Cross-Over Studies
  • Diabetes Mellitus, Type 2 (drug therapy)
  • Female
  • Glycemic Control
  • Humans
  • Insulin Resistance
  • Liver
  • Male
  • Rapeseed Oil
  • Sesame Oil
  • Sesamum

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: